Eduardo Marbán, MD, PhD, Cedars-Sinai Medical Center (IMAGE)

Cedars-Sinai Medical Center

Eduardo Marbán, MD, PhD, Cedars-Sinai Medical Center

Caption

"The need is great because there is no current treatment to address heart failure in these patients," said Eduardo Marbán, MD, PhD, director of the Cedars-Sinai Heart Institute and the researcher who developed the cardiosphere-derived cell (CDC) technology used in the study. "Generally, the primary cause of death in these patients is heart failure. If we can slow or reverse heart failure in Duchenne patients, it will be a step forward."

Credit

Cedars-Sinai

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.